Breast Cancer Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Breast Cancer Genomics

- Cancer PHGKB -

From HuGE Literature Finder Database

This database contains published literature on genetic associations and other human genome epidemiology

---

• Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women.  
  Journal of the National Cancer Institute 2017 Aug 109 (8): .
  Schmidt Marjanka K, van den Broek Alexandra J, Tollenaar Rob A E M, Smit Vincent T H B M, Westenend Pieter J, Brinkhuis Mariël, Oosterhuis Wolter J W, Wesseling Jelle, Janssen-Heijnen Maryska L, Jobsen Jan J, Jager Agnes, Voogd Adri C, van Leeuwen Flora E, van 't Veer Laura
• Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers.  
  Journal of the National Cancer Institute 2017 Jul 109 (7): .
  Kuchenbaecker Karoline B, McGuffog Lesley, Barrowdale Daniel, Lee Andrew, Soucy Penny, Dennis Joe, Domchek Susan M, Robson Mark, Spurdle Amanda B, Ramus Susan J, Mavaddat Nasim, Terry Mary Beth, Neuhausen Susan L, Schmutzler Rita Katharina, Simard Jacques, Pharoah Paul D P, Offit Kenneth, Couch Fergus J, Chenevix-Trench Georgia, Easton Douglas F, Antoniou Antonis
• Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.  
  Familial cancer 2017 May .
  Gabaldó Barrios Xavier, Sarabia Meseguer Mª Desamparados, Marín Vera Miguel, Sánchez Bermúdez Ana Isabel, Macías Cerrolaza José Antonio, Sánchez Henarejos Pilar, Zafra Poves Marta, García Hernández Mª Rosario, Cuevas Tortosa Encarna, Aliaga Baño Ángeles, Castillo Guardiola Verónica, Martínez Hernández Pedro, Tovar Zapata Isabel, Martínez Barba Enrique, Ayala de la Peña Francisco, Alonso Romero José Luis, Noguera Velasco José Antonio, Ruiz Espejo Francis
• Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib plus Capecitabine in HER2-Positive Advanced Breast Cancer Refractory to Trastuzumab.  
  Oncology 2017 May 93 (1): .
  Nishimura Reiki, Toh Uhi, Tanaka Maki, Saimura Michiyo, Okumura Yasuhiro, Saito Tsuyoshi, Tanaka Toshihiro, Teraoka Megumi, Shimada Kazuo, Katayama Kazuhisa, Koga Toshihiro, Kurashita Kaname, Hasegawa Satoshi, Todoroki Hidekazu, Kai Yuichiro, Ohi Yasuyo, Toyoshima Satoshi, Arima Nobuyuki, Mitsuyama Shoshu, Tamura Kaz
• The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium.  
  Journal of medical genetics 2017 May .
  Moghadasi Setareh, Meeks Huong D, Vreeswijk Maaike Pg, Janssen Linda Am, Borg Åke, Ehrencrona Hans, Paulsson-Karlsson Ylva, Wappenschmidt Barbara, Engel Christoph, Gehrig Andrea, Arnold Norbert, Hansen Thomas Van Overeem, Thomassen Mads, Jensen Uffe Birk, Kruse Torben A, Ejlertsen Bent, Gerdes Anne-Marie, Pedersen Inge Søkilde, Caputo Sandrine M, Couch Fergus, Hallberg Emily J, van den Ouweland Ans Mw, Collée Margriet J, Teugels Erik, Adank Muriel A, van der Luijt Rob B, Mensenkamp Arjen R, Oosterwijk Jan C, Blok Marinus J, Janin Nicolas, Claes Kathleen Bm, Tucker Kathy, Viassolo Valeria, Toland Amanda Ewart, Eccles Diana E, Devilee Peter, Van Asperen Christie J, Spurdle Amanda B, Goldgar David E, García Encarna Góm

more